DE3173713D1 - Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane - Google Patents
Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membraneInfo
- Publication number
- DE3173713D1 DE3173713D1 DE8181106848T DE3173713T DE3173713D1 DE 3173713 D1 DE3173713 D1 DE 3173713D1 DE 8181106848 T DE8181106848 T DE 8181106848T DE 3173713 T DE3173713 T DE 3173713T DE 3173713 D1 DE3173713 D1 DE 3173713D1
- Authority
- DE
- Germany
- Prior art keywords
- immunosome
- formation
- viral antigens
- artificial membrane
- exclusively made
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18426480A | 1980-09-05 | 1980-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3173713D1 true DE3173713D1 (en) | 1986-03-20 |
Family
ID=22676213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8181106848T Expired DE3173713D1 (en) | 1980-09-05 | 1981-09-02 | Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0047480B1 (de) |
JP (1) | JPH0676340B2 (de) |
DE (1) | DE3173713D1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8205892D0 (sv) * | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
US5897873A (en) * | 1984-04-12 | 1999-04-27 | The Liposome Company, Inc. | Affinity associated vaccine |
SE8405493D0 (sv) * | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
JPH0688911B2 (ja) * | 1985-06-06 | 1994-11-09 | 国立予防衛生研究所長 | インフルエンザワクチン及びその製造方法 |
US4790987A (en) * | 1985-11-15 | 1988-12-13 | Research Corporation | Viral glycoprotein subunit vaccine |
DK166762B1 (da) * | 1986-01-14 | 1993-07-12 | Nederlanden Staat | Fremgangsmaade til fremstilling af immunogenkomplekser og farmaceutisk sammensaetning indeholdende saadanne komplekser |
FR2595141B1 (fr) * | 1986-02-28 | 1989-05-26 | Inst Nat Sante Rech Med | Nouvelles compositions de liposomes contenant un des elements d'une reaction affine, procede pour leurs preparations et utilisation de ces compositions pour la detection de l'element complementaire de la reaction affine, notamment d'un antigene parasitaire |
US4861597A (en) * | 1986-05-20 | 1989-08-29 | Wako Pure Chemical Industries, Ltd. | Novel functionallized liposomes and a process for production thereof |
JPH07121871B2 (ja) * | 1986-10-09 | 1995-12-25 | 国立予防衛生研究所長 | インフルエンザワクチン凍結乾燥製剤 |
LU86736A1 (fr) * | 1987-01-15 | 1988-08-23 | Univ Bruxelles | Liposomes sensibilises a des molecules antigeniques de parasites intracellulaires,procede pour les preparations et leurs applications comme moyens de diagnostic et comme agents d'immunisation |
US5026557A (en) * | 1987-09-09 | 1991-06-25 | The Liposome Company, Inc. | Adjuvant composition |
FR2624741B1 (fr) * | 1987-12-21 | 1991-06-28 | Pasteur Institut | Compositions a base d'une combinaison de liposomes et de lymphokine presentant des proprietes immunostimulantes et leurs applications en medecine humaine et veterinaire |
NZ230424A (en) * | 1988-08-25 | 1992-05-26 | Liposome Co Inc | Liposomal composition comprising an externally disposed antigen |
ES2088960T3 (es) * | 1989-02-06 | 1996-10-01 | Wako Pure Chem Ind Ltd | Procedimiento de inmunoanalisis y reactivos liquidos utilizados para ello. |
IT1238343B (it) * | 1989-10-16 | 1993-07-13 | Cesalpino Andrea Fond | Procedimento per la preparazione di vaccini capaci di generare non solo la risposta immune dei linfociti t helper,ma anche un'efficace risposta di linfociti t citotossici,e vaccini con queste caratteristiche |
US5252348A (en) * | 1990-10-19 | 1993-10-12 | Univ. Of Florida Research Foundation, Inc. | Artificial viral envelopes |
DE69115924T2 (de) * | 1990-10-19 | 1996-05-23 | Univ Florida | Künstliche virushüllen |
US5753258A (en) * | 1990-10-19 | 1998-05-19 | University Of Florida | Artificial viral envelopes |
PL296382A1 (en) * | 1991-02-02 | 1993-11-02 | Nika Health Products Ltd Li Li | Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system |
JPH06500128A (ja) * | 1991-05-08 | 1994-01-06 | シュバイツ・ゼルム―・ウント・インプフィンスティテュート・ベルン | 免疫刺激及び免疫増強性再構成インフルエンザウイロソーム及びそれを含有するワクチン |
US5879685A (en) * | 1991-05-08 | 1999-03-09 | Schweiz, Serum- & Impfinstitut Bern | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
EP0850064A1 (de) * | 1995-09-14 | 1998-07-01 | Lxr Biotechnology Inc. | Anti-apoptose zusammensetzung die eine mischung von phospholipiden enthält |
FR2806912B1 (fr) * | 2000-04-04 | 2004-07-23 | Fond Mondiale Rech Et Preventi | UTILISATION DE PROTEINES gp120 ET gp160 MODIFIEES DANS LA BOUCLE V3 DU VIH-1 POUR LA PREPARATION DE COMPOSITIONS VACCINALES ET FORMULATIONS LES CONTENANT |
JP2013166699A (ja) * | 2010-05-28 | 2013-08-29 | National Institute Of Infectious Diseases | 不活化したウイルス粒子を含む複合体及びその用途 |
RU2443431C1 (ru) * | 2010-11-17 | 2012-02-27 | Николай Александрович Контаров | Способ профилактики и лечения гриппа в условиях предэпидемии и эпидемии и препарат для его осуществления |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1564500A (en) * | 1975-09-29 | 1980-04-10 | Wellcome Found | Biological preparations |
CH624011A5 (de) * | 1977-08-05 | 1981-07-15 | Battelle Memorial Institute | |
US4201767A (en) * | 1978-11-08 | 1980-05-06 | Merck & Co., Inc. | Viral liposome particle |
US4199565A (en) * | 1979-03-26 | 1980-04-22 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
US4235877A (en) * | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
-
1981
- 1981-09-02 DE DE8181106848T patent/DE3173713D1/de not_active Expired
- 1981-09-02 EP EP81106848A patent/EP0047480B1/de not_active Expired
- 1981-09-04 JP JP56139627A patent/JPH0676340B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS57118794A (en) | 1982-07-23 |
EP0047480A3 (en) | 1983-01-12 |
JPH0676340B2 (ja) | 1994-09-28 |
EP0047480B1 (de) | 1986-02-05 |
EP0047480A2 (de) | 1982-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3173713D1 (en) | Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane | |
JPS5786051A (en) | Determination of antigen employing two or more monochronal antibodies | |
GB2113551B (en) | Artificial joint | |
DE3164249D1 (en) | Immunoassay of antigens | |
EP0144493A3 (en) | Method of preparing asymmetric membranes | |
JPS57110257A (en) | Artificial kidney | |
JPS5783246A (en) | Artificial milk | |
GB8304538D0 (en) | Antibodies and antigens | |
AU7045581A (en) | Foot-and mouth disease viral antigens | |
AU546088B2 (en) | Isolation of viral glycoproter antigens | |
AU2493184A (en) | Specific cea-family antigens, antibodies specific thereto and their methods of use | |
GB8405212D0 (en) | Preparation of resorcinol | |
DE3070322D1 (en) | Prosthesis for the ossicles of the ear | |
ZA811945B (en) | Electromagnetic vibrating system operable at high amplitudes | |
GB2069925B (en) | Plasmaphoresis membrane | |
JPS5711400A (en) | Sound generating system | |
AU7475481A (en) | Artificial lung device | |
JPS5723087A (en) | Pretipitation of asbesto diaphragm and diaphragm prepared thereby | |
AU529307B2 (en) | Benzodiazepin adjuvants | |
JPS56152423A (en) | Manufacture of artificial erythrocyte | |
JPS57112798A (en) | Sound output system | |
GB2123650B (en) | Acoustic diaphragm | |
IT8026345A0 (it) | Procedimento e perfezionamento per la preparazione di dicumilperossido. | |
JPS56139459A (en) | Novel substituted 1h-indoles, manufacture and copying and recording system made thereof | |
JPS5743749A (en) | Hollow fiber membrane type artificial lung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |